Pro-apoptotic effects of rHSG on C6 glioma cells

Gao,Peng; Zou,Yourui; Zhang,Bing; Jiang,Shucai; Hao,Wenjiong; Guo,Hui; Huo,Guojin; Wang,Juncheng; Zhao,Wei; Shen,Bing

doi:10.3892/ijmm.2016.2725

Pro-apoptotic effects of rHSG on C6 glioma cells

Authors:
- Peng Gao
- Yourui Zou
- Bing Zhang
- Shucai Jiang
- Wenjiong Hao
- Hui Guo
- Guojin Huo
- Juncheng Wang
- Wei Zhao
- Bing Shen
View Affiliations

Affiliations: Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Graduate School of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Department of Neurosurgery, Yan'an University Affiliated Hospital, Yan'an, Shanxi 716000, P.R. China, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China, Medical Science and Technology Research Center, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China
Published online on: August 31, 2016 https://doi.org/10.3892/ijmm.2016.2725
Pages: 1190-1198
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Our previous in vitro study demonstrated that the rat hyperplasia suppressor gene (rHSG) inhibited the proliferation of C6 cells. In the present study, we investigated further the effects of rHSG overexpression on the apoptosis of C6 cells and the possible pathways involved. Hoechst 33342/PI double staining and comet assay were used to examine the morphological characteristics of apoptosis and to examine the effects of rHSG on the apoptosis of the C6 cells. Western blot analysis was used to determine the effects of rHSG overexpression on the protein expression levels of poly(ADP‑ribose) polymerase (PARP), cleaved caspase-3, phosphorylated extracellular signal-regulated kinase 1/2 (p-Erk1/2), phosphorylated Akt (p-Akt) and phosphoinositide 3-kinase (PI3K)/Akt, as well as on the mitogen-activated protein kinase (MAPK) pathways induced by insulin‑like growth factor (IGF)-1. Our results revealed that the C6 cells transfected with the rHSG adenoviral vector (Adv-rHSG-GFP group) efficiently expressed rHSG protein; Hoechst 33342/PI double staining and comet assay revealed that rHSG increased C6 cell apoptosis and induced DNA damage. Western blot analysis indicated that rHSG overexpression significantly increased the level of full-length PARP at 24 and 72 h (P<0.01), but decreased the level at 48 h following transfection (P<0.01), while the proteins levels of cleaved PARP and cleaved caspase-3 increased significantly (P<0.01). The protein expression of p-Erk1/2 and p-Akt began to decrease at 48 h post-transfection (P<0.01). In addition, the protein levels of Akt and Erk1/2 induced by IGF-1 were significantly inhibited. On the whole, the findings of the present study demonstrate that rHSG overexpression induces the apoptosis of rat glioma cells, and that these effects may involve the PI3K/Akt and MAPK pathways.

View Figures

View References

1	Fuller GN and Scheithauer BW: The 2007 Revised World Health Organization (WHO) classification of tumours of the central nervous system: newly codified entities. Brain Pathol. 17:304–307. 2007. View Article : Google Scholar : PubMed/NCBI
2	Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, Schnell O, Westphal M, Wick W, Pietsch T, Loeffler M, et al German Glioma Network: Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. Int J Cancer. 131:1342–1350. 2012. View Article : Google Scholar
3	Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB and Rosenfeld M: Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res. 16:2443–2449. 2010. View Article : Google Scholar : PubMed/NCBI
4	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
5	Chinese Glioma Cooperative Group (CGCG); Chinese Glioma Atlas (CGGA): Chinese Glioma Molecular Guidelines. Chin J Neurosurg. 30:435–444. 2014.
6	Candolfi M, Kroeger KM, Muhammad AK, Yagiz K, Farrokhi C, Pechnick RN, Lowenstein PR and Castro MG: Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety. Curr Gene Ther. 9:409–421. 2009. View Article : Google Scholar : PubMed/NCBI
7	Nakada M, Niska JA, Tran NL, McDonough WS and Berens ME: EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol. 167:565–576. 2005. View Article : Google Scholar : PubMed/NCBI
8	Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG and Hur MW: Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem. 283:33199–33210. 2008. View Article : Google Scholar : PubMed/NCBI
9	Westphal M and Lamszus K: The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci. 12:495–508. 2011. View Article : Google Scholar : PubMed/NCBI
10	Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP and Tang J: Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 6:872–883. 2004. View Article : Google Scholar : PubMed/NCBI
11	Guo X, Chen KH, Guo Y, Liao H, Tang J and Xiao RP: Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res. 101:1113–1122. 2007. View Article : Google Scholar : PubMed/NCBI
12	Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, et al: LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J Cell Biochem. 103:245–255. 2008. View Article : Google Scholar
13	Wu M, Huang C, Li X, Li X, Gan K, Chen Q, Tang Y, Tang K, Shen S and Li G: LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses. J Cell Physiol. 214:65–74. 2008. View Article : Google Scholar
14	Kunapuli P, Kasyapa CS, Hawthorn L and Cowell JK: LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway. J Biol Chem. 279:23151–23157. 2004. View Article : Google Scholar : PubMed/NCBI
15	Bhaskara VK, Sundaram C and Babu PP: pERK, pAkt and pBad: a possible role in cell proliferation and sustained cellular survival during tumorigenesis and tumor progression in ENU induced transplacental glioma rat model. Neurochem Res. 31:1163–1170. 2006. View Article : Google Scholar : PubMed/NCBI
16	Cuevas P, Diaz-González D, Carceller F and Dujovny M: Dual blockade of mitogen-activated protein kinases ERK-1 (p42) and ERK-2 (p44) and cyclic AMP response element binding protein (CREB) by neomycin inhibits glioma cell proliferation. Neurol Res. 25:13–16. 2003. View Article : Google Scholar : PubMed/NCBI
17	Belsey MJ, Davies AR, Witchel HJ and Kozlowski RZ: Inhibition of ERK and JNK decreases both osmosensitive taurine release and cell proliferation in glioma cells. Neurochem Res. 32:1940–1949. 2007. View Article : Google Scholar : PubMed/NCBI
18	Betti M, Minelli A, Canonico B, Castaldo P, Magi S, Aisa MC, Piroddi M, Di Tomaso V and Galli F: Antiproliferative effects of tocopherols (vitamin E) on murine glioma C6 cells: homologue-specific control of PKC/ERK and cyclin signaling. Free Radic Biol Med. 41:464–472. 2006. View Article : Google Scholar : PubMed/NCBI
19	McDaid HM, Lopez-Barcons L, Grossman A, Lia M, Keller S, Pérez-Soler R and Horwitz SB: Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants. Cancer Res. 65:2854–2860. 2005. View Article : Google Scholar : PubMed/NCBI
20	Knobbe CB, Trampe-Kieslich A and Reifenberger G: Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathol Appl Neurobiol. 31:486–490. 2005. View Article : Google Scholar : PubMed/NCBI
21	Gao P, Jiang S, Guo H, Yang Q, Fang Z, Zhao W and Shen B: Expression and mechanism of rat hyperplasia suppressor gene suppressing growth of rat C6 glioma cells. J Third Mil Med Univ. 36:381–385. 2014.
22	Jin B, Fu G, Pan H, Cheng X, Zhou L, Lv J, Chen G and Zheng S: Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol. 28(Suppl 1): S373–S380. 2011. View Article : Google Scholar
23	Wang W, Lu J, Zhu F, Wei J, Jia C, Zhang Y, Zhou L, Xie H and Zheng S: Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med Oncol. 29:70–76. 2012. View Article : Google Scholar
24	Gagné JP, Moreel X, Gagné P, Labelle Y, Droit A, Chevalier-Paré M, Bourassa S, McDonald D, Hendzel MJ, Prigent C and Poirier GG: Proteomic investigation of phosphorylation sites in poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase. J Proteome Res. 8:1014–1029. 2009. View Article : Google Scholar
25	Reed AM, Fishel ML and Kelley MR: Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiation. Future Oncol. 5:713–726. 2009. View Article : Google Scholar : PubMed/NCBI
26	Atorino L, Di Meglio S, Farina B, Jones R and Quesada P: Rat germinal cells require PARP for repair of DNA damage induced by gamma-irradiation and H₂O₂ treatment. Eur J Cell Biol. 80:222–229. 2001. View Article : Google Scholar : PubMed/NCBI
27	Thornberry NA and Lazebnik Y: Caspases: enemies within. Science. 281:1312–1316. 1998. View Article : Google Scholar : PubMed/NCBI
28	Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J and Fujii Y: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer. 95:92–95. 2001. View Article : Google Scholar : PubMed/NCBI
29	Altieri DC: Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 22:8581–8589. 2003. View Article : Google Scholar : PubMed/NCBI
30	Beardsmore DM, Verbeke CS, Davies CL, Guillou PJ and Clark GW: Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected]. J Gastrointest Surg. 7:77–86. 2003. View Article : Google Scholar
31	Kelly RJ, Lopez-Chavez A, Citrin D, Janik JE and Morris JC: Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Mol Cancer. 10:352011. View Article : Google Scholar : PubMed/NCBI
32	Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58:5315–5320. 1998.PubMed/NCBI
33	Boucher MJ, Morisset J, Vachon PH, Reed JC, Lainé J and Rivard N: MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem. 79:355–369. 2000. View Article : Google Scholar : PubMed/NCBI
34	Buder-Hoffmann S, Palmer C, Vacek P, Taatjes D and Mossman B: Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells. Am J Respir Cell Mol Biol. 24:405–413. 2001. View Article : Google Scholar : PubMed/NCBI
35	Neri LM, Borgatti P, Capitani S and Martelli AM: The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta. 1584:73–80. 2002. View Article : Google Scholar : PubMed/NCBI
36	Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC and Kahn CR: Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol. 22:965–977. 2002. View Article : Google Scholar : PubMed/NCBI
37	Wymann MP and Pirola L: Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta. 1436:127–150. 1998. View Article : Google Scholar : PubMed/NCBI
38	Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E and Cobb MH: Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell. 93:605–615. 1998. View Article : Google Scholar : PubMed/NCBI
39	Párrizas M, Saltiel AR and LeRoith D: Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem. 272:154–161. 1997. View Article : Google Scholar
40	Kenchappa P, Yadav A, Singh G, Nandana S and Banerjee K: Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases. J Neurosci Res. 76:466–474. 2004. View Article : Google Scholar : PubMed/NCBI
41	Bencomo E, Pérez R, Arteaga MF, Acosta E, Peña O, Lopez L, Avila J and Palumbo A: Apoptosis of cultured granulosa-lutein cells is reduced by insulin-like growth factor I and may correlate with embryo fragmentation and pregnancy rate. Fertil Steril. 85:474–480. 2006. View Article : Google Scholar : PubMed/NCBI
42	Gao P, Wang Z, Zhang B, Zou Y, Guo H, Liu H, Yang Q, Fang Z, Jiang S, Shen B, et al: Suppression of C6 gliomas via application of rat hyperplasia gene. Int J Biol Markers. 29:e411–e422. 2014. View Article : Google Scholar : PubMed/NCBI